UMEM Educational Pearls

Title: Combination Therapy for Bacteremia

Category: Critical Care

Keywords: staphylococcal aureus, aminoglycoside, monotherapy, combination therapy (PubMed Search)

Posted: 4/19/2011 by Mike Winters, MBA, MD (Updated: 11/25/2024)
Click here to contact Mike Winters, MBA, MD

Combination Antimicrobial Therapy for Gram (+) Bacteremia

  • Bacteremia is a major cause of morbidity and mortality in the critically ill patient.
  • S.aureus remains a common isolate in patients with either hospital-acquired or community-acquired bacteremia.
  • In cases of suspected endocarditis due to S.aureus, traditional teaching has been to give an aminoglycoside (i.e. gentamicin) in combination with vancomycin or an antistaphylococcal penicillin.
  • Importantly, there is no strong evidence to support this combination in patients with suspected S.aureus bacteremia.
  • Furthermore, patients receiving the aminoglycoside combination have higher rates of renal impairment without any added clinical benefit.

References

Abad CL, Kumar A, Safdar N. Antimicrobial therapy of sepsis and septic shock - When are two drugs better than one? Crit Care Clin 2011;27:e1-e27.